Kimberly F. Nice, PhD
Senior Clinical Research Scientist
Kimberly F. Nice, PhD is a Senior Clinical Research Scientist at IMPACT. Prior to joining IMPACT, she was a group manager and Senior Clinical Research Scientist for Regulatory Affairs and Strategic Drug Development Services at SRA International (formerly Constella Group) (public company; 1001-5000 employees). She joined SRA through acquisition of Lineberry Research Associates (LRA) into the Constella Group in 2006. She started at LRA in 2005 as a Clinical Research Scientist and was with LRA/Constella/SRA for four years.
Dr. Nice has led teams on a number of complex regulatory writing and consulting projects. She has experience writing and reviewing both regulatory and non-regulatory documents, including INDs, clinical summary and integrated summary documents for NDAs, CSRs, protocols, investigator’s brochures, and safety narratives. In addition, Dr. Nice has managed the submission and maintenance of INDs. This work has encompassed a broad-range of therapeutic areas including analgesia/pain management, cardiovascular, restless legs syndrome, vaccines, and Women’s Health.
Dr. Nice has three years of postdoctoral training in reproductive biology and contraception at the University of Virginia Medical Center. She received a BS in biotechnology from the University of Kentucky, an MS in reproductive physiology from Kansas State University, and a PhD in pharmacology from the University of Texas Health Science Center – San Antonio.